compulsory patent licensing india
Asia Pacific Laws, Biosimilars, Biosimilars and Biologics, Biotech Patents, Biotechnology Patents, Intellectual Property Rights Protection, Laws - Intellectual Property Rights, patent attorney india, Patent Publications - Technology, Business and Law, patent services, Patents, Patents Granted by Patent Office, Pharmaceutical Patents

BioSpectrum Asia – Compulsory License of Bayer’s Nexavar

BioSpectrum Asia - Debate over compulsory licensing of Bayer's Nexavar  Originally published here. Full Article: India allows compulsory licensing of Bayer’s Nexavar In March 2012, the Indian Patent office granted first compulsory license to NATCO pharma to make anti-cancer drug sorafenib for the India market. However, the compulsory license is subject to certain conditions, such… Continue reading BioSpectrum Asia – Compulsory License of Bayer’s Nexavar

Advertisements